Life Science Compliance Update

February

2016

COMMENTS

0

Your Special Relationships – Specialty Pharmacies and 5 Thoughtful Controls to Consider

Written by , Posted in Abstract, Specialty Pharmacies

By Jack Tanselle – Managing Director, John Moose – Director, Samantha Sutherland – Associate and Mark DeWyngaert – Managing Director from Huron Life Sciences

The Government and other regulators are now focusing more on initiative relationships between pharmaceutical companies and other customer entities, beyond those relationships with individual healthcare professionals (HCPs).  One area of increased focus involves specialty pharmacies.  This article explores those relationships and suggests controls that compliance officers should consider.

Menu Title